November 8, 2022

More COVID-19 Vaccine Symptoms Signal Better Antibody Response

As the primary vaccinators during the COVID-19 pandemic, pharmacists have fielded a lot of questions and concerns about mild adverse effects from mRNA shots. A new study published in the Journal of the American Medical Association provided evidence for a new response: Those symptoms are actually associated with improved vaccine-induced antibody response. Learn more about what this study had to say.


Factors That Increase Pancreatitis Risk With GLP-1 Initiation

Glucagon-like peptide 1 (GLP-1) receptor agonists are effective and widely used for both type 2 diabetes and weight loss. The downside, however, is that the drugs cause acute pancreatitis in some patients. Find out what factors make that adverse effect much more likely from a presentation given at the American College of Gastroenterology’s Annual Scientific Meeting in Charlotte, North Carolina.

Emails From Pharmacists Not Effective in Reducing Risky Coprescribing

A new clinical trial that was published in the Journal of the American Medical Association Health Forum by researchers at Columbia University Mailman School of Public Health in New York and colleagues had the following premise: If coprescribing benzodiazepines with opioids leads to adverse patient outcomes, alerts from pharmacists should help curtail the practice. Yet, that is not what occurred. Read more.


More Than 930,000 Vaccine Doses Administered for Monkeypox

In an effort to prevent and reduce the severity of monkeypox, 931,155 doses of the Jynneos vaccine were administered and reported to the CDC from May 22, 2022, to October 10, 2022. New statistics published on October 28, 2022, in the CDC’s Morbidity & Mortality Weekly Report show where the vaccines were available and who received them. Read more.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -